{"id":11266,"date":"2018-01-08T23:00:00","date_gmt":"2018-01-08T22:00:00","guid":{"rendered":"https:\/\/lombardialifesciences.it\/biopolmeri-per-il-settore-medico\/"},"modified":"2023-06-22T22:16:15","modified_gmt":"2023-06-22T20:16:15","slug":"biopolmeri-per-il-settore-medico","status":"publish","type":"post","link":"https:\/\/lombardialifesciences.it\/en\/biopolmeri-per-il-settore-medico\/","title":{"rendered":"Biopolmeri per il settore medico"},"content":{"rendered":"<p><p>Allergan wants to extend their project portfolio in <strong>biopolymers for medical injectable and\/or implantable applications<\/strong> through initiating new partnerships with academic or biotech partners.<\/p>\n<p>Allergan is especially focused on <strong>structural proteins and biopolymers found in skin and soft tissues<\/strong>, such as:<\/p>\n<ul>\n<li>Glycosaminoglycans (GAGs): hyaluronic acid, heparan sulfate, heparosan, dermatan sulfate, chitosan, chondroitin sulfate<\/li>\n<li>Integrin extracellular ligands: collagen, elastin, polylysine, fibronectin, laminin, nidogens, osteopontin, \u2026<\/li>\n<li>Peptides: RGD peptides, Pal KTTKS, elastin-like peptide (ELP),\u2026<\/li>\n<\/ul>\n<p>Allergan is trying to identify projects related to such biopolymers and proteins for medical injectable and\/or implantable applications.<\/p>\n<p>Allergan is looking for projects <strong>from preclinical stage <\/strong>(with an emphasis on in vivo projects) <strong>to recently marketed products.<\/strong><\/p>\n<p>Fore more informations, please contact: <a href=\"mailto:laetitia.duret@erdyn.fr\" style=\"color: purple; text-decoration: underline; font-family: Calibri, sans-serif; font-size: 15px;\">laetitia.duret@erdyn.fr<\/a><\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Allergan wants to extend their project portfolio in biopolymers for medical injectable and\/or implan&#8230;<\/p>\n","protected":false},"author":1,"featured_media":11267,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[44],"tags":[],"class_list":["post-11266","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/11266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/comments?post=11266"}],"version-history":[{"count":1,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/11266\/revisions"}],"predecessor-version":[{"id":16645,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/11266\/revisions\/16645"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media\/11267"}],"wp:attachment":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media?parent=11266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/categories?post=11266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/tags?post=11266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}